Michael Pollan
Psychedelics are experiencing a scientific renaissance, revealing profound potential to treat mental health disorders by temporarily dissolving the ego and shifting our perspective on reality.
Psychedelics interact with serotonin receptors to quiet the Default Mode Network, the brain system responsible for our sense of ego and self-reflection.
Decreased activity in this network creates a state of cognitive flexibility that helps adults break free from rigid habits like addiction and depression.
Clinical trials show that patients facing terminal cancer experience significant and lasting reductions in anxiety after a single guided psilocybin session.